Recovery from heart failure with circulatory assist: A working group of the national, heart, lung, and blood institute

被引:16
|
作者
Reinlib, L
Abraham, W
机构
[1] US Dept HHS, NHLBI, Div Heart & Vasc Dis, NIH, Bethesda, MD USA
[2] Ohio State Univ, Div Cardiol, Columbus, OH 43210 USA
关键词
heart failure; LVAD; circulatory assist; devices; mechanical circulatory support;
D O I
10.1016/S1071-9164(03)00592-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Over the past decade, mechanical circulatory support has been beneficial as a bridge to cardiac transplantation, and anecdotal evidence suggests that heart failure patients fitted with mechanical assist devices experience direct cardiac benefits. Moreover, recent trials on limited numbers and subpopulations of patients-notably the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH)-support earlier observations of improved cardiac function and point towards the use of assist devices as destination therapy. Methods and Results: To investigate this phenomenon, on August 2-3, 2001, the National Heart, Lung, and Blood Institute convened the working group, "Recovery from Heart Failure with Circulatory Assist" in Bethesda, Maryland. The team included cardiac surgeons, cardiologists, and experts in experimental research. The goal was to prioritize recommendations to guide future programs in: (1) elucidating the mechanisms leading to reverse remodeling associated with a left ventricular assist device (LVAD); (2) exploring advanced treatments, including novel pharmacologies, tissue engineering, and cell therapies, to optimize recovery with LVAD therapy; and (3) identifying target genes, proteins, and cellular pathways to focus on for production of novel therapies for myocardial recovery and cardiovascular disease. Conclusions: The working group also made research and clinical recommendations to eventually translate findings into improved therapeutic strategies and device design: (1) support collaborations among clinical and basic scientists with an emphasis on clinical/translational research that might eventually lead to clinical trials; (2) identify candidate patients most likely to benefit from LVAD as a destination therapy; (3) explore potential biomarkers indicating when patients could most successfully be weaned from devices; and (4) promote clinical and experimental study of mechanically assisted organs and the tissue derived from them.
引用
收藏
页码:459 / 463
页数:5
相关论文
共 50 条
  • [41] Report of the National Heart, Lung, and Blood Institute's Working Group on Obesity and Other Cardiovascular Risk Factors in Congenital Heart Disease
    Pemberton, Victoria L.
    McCrindle, Brian W.
    Barkin, Shari
    Daniels, Stephen R.
    Barlow, Sarah E.
    Binns, Helen J.
    Cohen, Meryl S.
    Economos, Christina
    Faith, Myles S.
    Gidding, Samuel S.
    Goldberg, Caren S.
    Kavey, Rae-Ellen
    Longmuir, Patricia
    Rocchini, Albert P.
    Van Horn, Linda
    Kaltman, Jonathan R.
    CIRCULATION, 2010, 121 (09) : 1153 - 1159
  • [42] Assessment and treatment of depression in patients with cardiovascular disease:: National Heart, Lung, and Blood Institute Working Group Report
    Davidson, Karina. W.
    Kupfer, David J.
    Bigger, J. Thomas
    Califf, Robert M.
    Carney, Robert M.
    Coyne, James C.
    Czajkowski, Susan M.
    Frank, Ellen
    Frasure-Smith, Nancy
    Freedland, Kenneth E.
    Froelicher, Erika S.
    Glassman, Alexander H.
    Katon, Wayne J.
    Kaufmann, Peter G.
    Kessler, Ronald C.
    Kraemer, Helena C.
    Krishnan, K. Ranga R.
    Lesperance, Francois
    Rieckmann, Nina
    Sheps, David S.
    Suls, Jerry M.
    ANNALS OF BEHAVIORAL MEDICINE, 2006, 32 (02) : 121 - 126
  • [43] Future research directions in idiopathic pulmonary fibrosis - Summary of a National Heart, Lung, and Blood Institute working group
    Crystal, RG
    Bitterman, PB
    Mossman, B
    Schwarz, MI
    Sheppard, D
    Almasy, L
    Chapman, HA
    Friedman, SL
    King, TE
    Leinwand, LA
    Liotta, L
    Martin, GR
    Schwartz, DA
    Schultz, GS
    Wagner, CR
    Musson, RA
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (02) : 236 - 246
  • [44] Assessment and treatment of depression in patients with cardiovascular disease:: National Heart, Lung, and Blood Institute working group report
    Davidson, Karina W.
    Kupfer, David J.
    Bigger, J. Thomas
    Califf, Robert M.
    Carney, Robert M.
    Coyne, James C.
    Czajkowski, Susan M.
    Frank, Ellen
    Frasure-Smith, Nancy
    Freedland, Kenneth E.
    Froelicher, Erika S.
    Glassman, Alexander H.
    Katon, Wayne L.
    Kaufmann, Peter G.
    Kessler, Ronald C.
    Kraemer, Helena C.
    Krishnan, K. Ranga R.
    Lesperance, Francois
    Rieckmann, Nina
    Sheps, David S.
    Suls, Jerry M.
    PSYCHOSOMATIC MEDICINE, 2006, 68 (05): : 645 - 650
  • [45] Report of the national heart, lung and blood institute-National Institute of Allergy and Infectious Diseases Working Group on antimicrobial strategies and cardiothoracic surgery
    Lowy, FD
    Waldhausen, JA
    Miller, M
    Sopko, G
    Rosenberg, Y
    Skarlatos, SI
    AMERICAN HEART JOURNAL, 2004, 147 (04) : 575 - 581
  • [46] Report of the National Heart, Lung, and Blood Institute and National Marfan Foundation working group on research in Marfan syndrome and related disorders
    Pearson, Gail D.
    Devereux, Richard
    Loeys, Bart
    Maslen, Cheryl
    Milewicz, Dianna
    Pyeritz, Reed
    Ramirez, Francesco
    Rifkin, Daniel
    Sakai, Lynn
    Svensson, Lars
    Wessels, Andy
    Van Eyk, Jennifer
    Dietz, Harry C.
    CIRCULATION, 2008, 118 (07) : 785 - 791
  • [47] Notes from the Director, National Heart, Lung, and Blood Institute: transitions
    Nabel, Elizabeth G.
    BLOOD, 2009, 113 (13) : 2875 - 2877
  • [48] The Influence of Biostatistics at the National Heart, Lung, and Blood Institute
    DeMets, David L.
    Wittes, Janet Turk
    Geller, Nancy L.
    AMERICAN STATISTICIAN, 2015, 69 (02): : 108 - 120
  • [49] RESEARCH PROGRAMS OF THE NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
    ROTH, CA
    LENFANT, JDC
    COR ET VASA, 1989, 31 (02) : 81 - 89
  • [50] Cardiovascular Pharmacogenomics: Current Status and Future Directions-Report of a National Heart, Lung, and Blood Institute Working Group
    Musunuru, Kiran
    Roden, Dan M.
    Boineau, Robin
    Bristow, Michael R.
    McCaffrey, Timothy A.
    Newton-Cheh, Christopher
    Paltoo, Dina N.
    Rosenberg, Yves
    Wohlgemuth, Jay G.
    Zineh, Issam
    Hasan, Ahmed A. K.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2012, 1 (02):